Literature DB >> 7054275

Binding affinities of anti-acetylcholine receptor autoantibodies in myasthenia gravis.

J J Bray, D B Drachman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7054275

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  7 in total

1.  HLA antigens in penicillamine induced myasthenia gravis.

Authors:  A Vincent; J Newsom-Davis
Journal:  Br Med J (Clin Res Ed)       Date:  1983-03-12

2.  HLA antigens and acetylcholine receptor antibodies in penicillamine induced myasthenia gravis.

Authors:  M I Garlepp; R L Dawkins; F T Christiansen
Journal:  Br Med J (Clin Res Ed)       Date:  1983-04-30

3.  Molecular mimicry and myasthenia gravis. An autoantigenic site of the acetylcholine receptor alpha-subunit that has biologic activity and reacts immunochemically with herpes simplex virus.

Authors:  P L Schwimmbeck; T Dyrberg; D B Drachman; M B Oldstone
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

4.  Effects of the rate of acetylcholine receptor synthesis on the severity of experimental autoimmune myasthenia gravis.

Authors:  M H De Baets; J Verschuuren; M R Daha; P J van Breda Vriesman
Journal:  Immunol Res       Date:  1988       Impact factor: 2.829

5.  Protective effect of myasthenic immunoglobulins against the lethal toxicity of alpha bungarotoxin.

Authors:  B Vernet-der Garabedian; J F Bach; E Morel
Journal:  Clin Exp Immunol       Date:  1987-04       Impact factor: 4.330

6.  HLA antigens and acetylcholine receptor antibodies in penicillamine induced myasthenia gravis.

Authors:  M J Garlepp; R L Dawkins; F T Christiansen
Journal:  Br Med J (Clin Res Ed)       Date:  1983-01-29

7.  Immunocompetent autoreactive B lymphocytes are activated cycling cells in normal mice.

Authors:  D Portnoï; A Freitas; D Holmberg; A Bandeira; A Coutinho
Journal:  J Exp Med       Date:  1986-07-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.